While transsphenoidal surgery is associated with low morbidity, the degree to which morbidity increases after reoperation remains unclear. The authors determined the morbidity associated with repeat versus initial transsphenoidal surgery after 1015 consecutive operations.
The authors conducted a 5-year retrospective review of the first 916 patients undergoing transsphenoidal surgery at their institution after a pituitary center of expertise was established, and they analyzed morbidities.
The authors analyzed 907 initial and 108 repeat transsphenoidal surgeries performed in 916 patients (9 initial surgeries performed outside the authors' center were excluded). The most common diagnoses were endocrine inactive (30%) or active (36%) adenomas, Rathke's cleft cysts (10%), and craniopharyngioma (3%). Morbidity of initial surgery versus reoperation included diabetes insipidus ([DI] 16% vs 26%; p = 0.03), postoperative hyponatremia (20% vs 16%; p = 0.3), new postoperative hypopituitarism (5% vs 8%; p = 0.3), CSF leak requiring repair (1% vs 4%; p = 0.04), meningitis (0.4% vs 3%; p = 0.02), and length of stay ([LOS] 2.8 vs 4.5 days; p = 0.006). Of intraoperative parameters and postoperative morbidities, 1) some (use of lumbar drain and new postoperative hypopituitarism) did not increase with second or subsequent reoperations (p = 0.3–0.9); 2) some (DI and meningitis) increased upon second surgery (p = 0.02–0.04) but did not continue to increase for subsequent reoperations (p = 0.3–0.9); 3) some (LOS) increased upon second surgery and increased again for subsequent reoperations (p < 0.001); and 4) some (postoperative hyponatremia and CSF leak requiring repair) did not increase upon second surgery (p = 0.3) but went on to increase upon subsequent reoperations (p = 0.001–0.02). Multivariate analysis revealed that operation number, but not sex, age, pathology, radiation therapy, or lesion size, increased the risk of CSF leak, meningitis, and increased LOS. Separate analysis of initial versus repeat transsphenoidal surgery on the 2 most common benign pituitary lesions, pituitary adenomas and Rathke's cleft cysts, revealed that the increased incidence of DI and CSF leak requiring repair seen when all pathologies were combined remained significant when analyzing only pituitary adenomas and Rathke's cleft cysts (DI, 13% vs 35% [p = 0.001]; and CSF leak, 0.3% vs 9% [p = 0.0009]).
Repeat transsphenoidal surgery was associated with somewhat more frequent postoperative DI, meningitis, CSF leak requiring repair, and greater LOS than the low morbidity characterizing initial transsphenoidal surgery. These results provide a framework for neurosurgeons in discussing reoperation for pituitary disease with their patients.
BarkerFGII, , KlibanskiA, & SwearingenB: Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab88:4709–4719, 2003
BarkerFGII, KlibanskiA, SwearingenB: Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab88:4709–4719, 200310.1210/jc.2003-030461)| false
BradaM, , RajanB, , TraishD, , AshleyS, , Holmes-SellorsPJ, & NusseyS, et al.: The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf)38:571–578, 1993
BradaM, RajanB, TraishD, AshleyS, Holmes-SellorsPJ, NusseyS, : The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf)38:571–578, 199310.1111/j.1365-2265.1993.tb02137.x)| false
ChangEF, , SughrueME, , ZadaG, , WilsonCB, , BlevinsLSJr, & KunwarS: Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas. Pituitary13:223–229, 2010
ChangEF, SughrueME, ZadaG, WilsonCB, BlevinsLSJr, KunwarS: Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas. Pituitary13:223–229, 201010.1007/s11102-010-0221-z)| false
ChangSM, , ParneyIF, , McDermottM, , BarkerFGII, , SchmidtMH, & HuangW, et al.: Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg98:1175–1181, 2003
ChangSM, ParneyIF, McDermottM, BarkerFGII, SchmidtMH, HuangW, : Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg98:1175–1181, 200310.3171/jns.2003.98.6.1175)| false
CiricI, RaginA, BaumgartnerC, PierceD: Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery40:225–237, 199710.1097/00006123-199702000-00001)| false
FurtadoSV, , ThakarS, & HegdeAS: The use of image guidance in avoiding vascular injury during trans-sphenoidal access and decompression of recurrent pituitary adenomas. J Craniomaxillofac Surg40:680–684, 2012
FurtadoSV, ThakarS, HegdeAS: The use of image guidance in avoiding vascular injury during trans-sphenoidal access and decompression of recurrent pituitary adenomas. J Craniomaxillofac Surg40:680–684, 201210.1016/j.jcms.2011.12.002)| false
LawsERJr, FodeNC, RedmondMJ: Transsphenoidal surgery following unsuccessful prior therapy An assessment of benefits and risks in 158 patients. J Neurosurg63:823–829, 198510.3171/jns.1985.63.6.0823)| false
YamadaS, FukuharaN, OyamaK, TakeshitaA, TakeuchiY: Repeat transsphenoidal surgery for the treatment of remaining or recurring pituitary tumors in acromegaly. Neurosurgery67:949–956, 201010.1227/NEU.0b013e3181ec4379)| false